• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阐明调节细胞凋亡的泛素蛋白酶体系统的串扰机制。

Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis.

作者信息

Gupta Ishita, Singh Kanika, Varshney Nishant K, Khan Sameena

机构信息

Structural Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.

Drug Discovery Research Centre, Translational Health Science and Technology Institute, Faridabad, India.

出版信息

Front Cell Dev Biol. 2018 Feb 9;6:11. doi: 10.3389/fcell.2018.00011. eCollection 2018.

DOI:10.3389/fcell.2018.00011
PMID:29479529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5811474/
Abstract

Regulatory functions of the ubiquitin-proteasome system (UPS) are exercised mainly by the ubiquitin ligases and deubiquitinating enzymes. Degradation of apoptotic proteins by UPS is central to the maintenance of cell health, and deregulation of this process is associated with several diseases including tumors, neurodegenerative disorders, diabetes, and inflammation. Therefore, it is the view that interrogating protein turnover in cells can offer a strategy for delineating disease-causing mechanistic perturbations and facilitate identification of drug targets. In this review, we are summarizing an overview to elucidate the updated knowledge on the molecular interplay between the apoptosis and UPS pathways. We have condensed around 100 enzymes of UPS machinery from the literature that ubiquitinates or deubiquitinates the apoptotic proteins and regulates the cell fate. We have also provided a detailed insight into how the UPS proteins are able to fine-tune the intrinsic, extrinsic, and p53-mediated apoptotic pathways to regulate cell survival or cell death. This review provides a comprehensive overview of the potential of UPS players as a drug target for cancer and other human disorders.

摘要

泛素-蛋白酶体系统(UPS)的调节功能主要由泛素连接酶和去泛素化酶行使。UPS对凋亡蛋白的降解是维持细胞健康的核心,该过程的失调与包括肿瘤、神经退行性疾病、糖尿病和炎症在内的多种疾病相关。因此,有一种观点认为,研究细胞中的蛋白质周转可以为描绘致病机制扰动提供一种策略,并有助于识别药物靶点。在这篇综述中,我们总结了一个概述,以阐明关于凋亡与UPS途径之间分子相互作用的最新知识。我们从文献中汇总了大约100种UPS机制中的酶,这些酶可使凋亡蛋白泛素化或去泛素化,并调节细胞命运。我们还详细介绍了UPS蛋白如何能够微调内在、外在和p53介导的凋亡途径以调节细胞存活或细胞死亡。这篇综述全面概述了UPS相关蛋白作为癌症和其他人类疾病药物靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/931db44d1653/fcell-06-00011-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/fbcb358c772f/fcell-06-00011-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/f987c55a18e2/fcell-06-00011-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/4a53a5910466/fcell-06-00011-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/fda2f2b324ac/fcell-06-00011-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/afd9ed14c92c/fcell-06-00011-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/931db44d1653/fcell-06-00011-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/fbcb358c772f/fcell-06-00011-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/f987c55a18e2/fcell-06-00011-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/4a53a5910466/fcell-06-00011-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/fda2f2b324ac/fcell-06-00011-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/afd9ed14c92c/fcell-06-00011-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d98e/5811474/931db44d1653/fcell-06-00011-g0006.jpg

相似文献

1
Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis.阐明调节细胞凋亡的泛素蛋白酶体系统的串扰机制。
Front Cell Dev Biol. 2018 Feb 9;6:11. doi: 10.3389/fcell.2018.00011. eCollection 2018.
2
E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway.E3 泛素连接酶和去泛素化酶作为 TRAIL 介导的外在凋亡信号通路的调节剂。
BMB Rep. 2019 Feb;52(2):119-126. doi: 10.5483/BMBRep.2019.52.2.011.
3
Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases.天然产物靶向泛素-蛋白酶体途径:治疗神经退行性疾病的新治疗策略
Front Physiol. 2020 Apr 28;11:361. doi: 10.3389/fphys.2020.00361. eCollection 2020.
4
The potential roles of deubiquitinating enzymes in brain diseases.去泛素化酶在脑部疾病中的潜在作用。
Ageing Res Rev. 2020 Aug;61:101088. doi: 10.1016/j.arr.2020.101088. Epub 2020 May 26.
5
Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?泛素-蛋白酶体系统在脑缺血中的作用:是敌是友?
Prog Neurobiol. 2014 Jan;112:50-69. doi: 10.1016/j.pneurobio.2013.10.003. Epub 2013 Oct 22.
6
Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.泛素蛋白酶体系统的潜在靶点:预防糖尿病肾病
Pharmacol Res. 2017 Jun;120:170-179. doi: 10.1016/j.phrs.2017.03.024. Epub 2017 Mar 29.
7
Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System.降解致死:泛素-蛋白酶体系统对细胞凋亡的调控。
Cells. 2021 Dec 8;10(12):3465. doi: 10.3390/cells10123465.
8
Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases.去泛素化酶调控神经退行性疾病中的细胞功能。
Ageing Res Rev. 2021 Aug;69:101367. doi: 10.1016/j.arr.2021.101367. Epub 2021 May 21.
9
Ubiquitin Engineering for Interrogating the Ubiquitin-Proteasome System and Novel Therapeutic Strategies.泛素工程用于探究泛素蛋白酶体系统和新型治疗策略。
Cells. 2023 Aug 21;12(16):2117. doi: 10.3390/cells12162117.
10
Proteasome-associated deubiquitinases and cancer.蛋白酶体相关去泛素化酶与癌症
Cancer Metastasis Rev. 2017 Dec;36(4):635-653. doi: 10.1007/s10555-017-9697-6.

引用本文的文献

1
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?增强大脑清理能力:靶向泛素蛋白酶体系统基因能否提供神经保护?
Mol Neurobiol. 2025 Aug 16. doi: 10.1007/s12035-025-05263-z.
2
Suppressing proteasome activity enhances sensitivity to actinomycin D in diffuse anaplastic Wilms tumor.抑制蛋白酶体活性可增强弥漫性间变性肾母细胞瘤对放线菌素D的敏感性。
Cell Rep Med. 2025 May 20;6(5):102133. doi: 10.1016/j.xcrm.2025.102133. Epub 2025 May 9.
3
Loss of correlated proteasomal subunit expression selectively promotes the 20S state which underlies luminal breast tumorigenicity.

本文引用的文献

1
Molecular basis of USP7 inhibition by selective small-molecule inhibitors.选择性小分子抑制剂对USP7抑制作用的分子基础
Nature. 2017 Oct 26;550(7677):481-486. doi: 10.1038/nature24451. Epub 2017 Oct 18.
2
Ixazomib: A Review in Relapsed and/or Refractory Multiple Myeloma.伊沙佐米:在复发性和/或难治性多发性骨髓瘤中的研究进展。
Target Oncol. 2017 Aug;12(4):535-542. doi: 10.1007/s11523-017-0504-7.
3
MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-κB and negatively regulates inflammatory responses.MKRN2 是 NF-κB p65 亚基的一种新型泛素 E3 连接酶,负调控炎症反应。
相关蛋白酶体亚基表达的丧失选择性地促进了20S状态,这是管腔型乳腺肿瘤发生的基础。
Commun Biol. 2025 Jan 15;8(1):55. doi: 10.1038/s42003-024-07432-7.
4
Exploring paraptosis as a therapeutic approach in cancer treatment.探讨细胞皱缩现象作为癌症治疗的一种治疗方法。
J Biomed Sci. 2024 Nov 4;31(1):101. doi: 10.1186/s12929-024-01089-4.
5
The Role of Deubiquitinating Enzymes in Primary Bone Cancer.去泛素化酶在原发性骨癌中的作用
Mol Biotechnol. 2024 Aug 23. doi: 10.1007/s12033-024-01254-y.
6
Notopterygium Incisum Extract Promotes Apoptosis by Preventing the Degradation of BIM in Colorectal Cancer.羌活提取物通过防止 BIM 在结直肠癌中的降解来促进细胞凋亡。
Curr Med Sci. 2024 Aug;44(4):833-840. doi: 10.1007/s11596-024-2883-1. Epub 2024 Jul 5.
7
Actinomycin D and bortezomib disrupt protein homeostasis in Wilms tumor.放线菌素D和硼替佐米干扰肾母细胞瘤中的蛋白质稳态。
bioRxiv. 2024 Dec 17:2024.06.11.598518. doi: 10.1101/2024.06.11.598518.
8
Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors.蛋白酶体抑制剂与 NF-κB 通路在白血病和淋巴瘤中的相互作用:蛋白酶体抑制剂面临挑战的综合述评。
Cell Commun Signal. 2024 Feb 8;22(1):105. doi: 10.1186/s12964-023-01433-5.
9
Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning.基于集成机器学习的肥厚型心肌病诊断基因生物标志物预测。
J Int Med Res. 2023 Nov;51(11):3000605231213781. doi: 10.1177/03000605231213781.
10
Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis.蛋白酶体抑制剂MG132通过ROS/DNA损伤/p53轴增强人口腔鳞状细胞癌(OSCC)细胞对顺铂的敏感性。
Exp Ther Med. 2023 Mar 30;25(5):224. doi: 10.3892/etm.2023.11924. eCollection 2023 May.
Sci Rep. 2017 Apr 5;7:46097. doi: 10.1038/srep46097.
4
Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma.新型蛋白酶体抑制剂德兰佐米布(CEP-18770)用于复发和难治性多发性骨髓瘤的I/II期研究。
Leuk Lymphoma. 2017 Aug;58(8):1872-1879. doi: 10.1080/10428194.2016.1263842. Epub 2017 Jan 31.
5
Proteasome inhibitors in cancer therapy.蛋白酶体抑制剂在癌症治疗中的应用。
Nat Rev Clin Oncol. 2017 Jul;14(7):417-433. doi: 10.1038/nrclinonc.2016.206. Epub 2017 Jan 24.
6
TRIM22-Mediated Apoptosis is Associated with Bak Oligomerization in Monocytes.TRIM22 介导的细胞凋亡与单核细胞中 Bak 寡聚化有关。
Sci Rep. 2017 Jan 12;7:39961. doi: 10.1038/srep39961.
7
Regulation of XIAP Turnover Reveals a Role for USP11 in Promotion of Tumorigenesis.XIAP 周转的调控揭示了 USP11 在促进肿瘤发生中的作用。
EBioMedicine. 2017 Feb;15:48-61. doi: 10.1016/j.ebiom.2016.12.014. Epub 2016 Dec 23.
8
Otub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria.Otub1可稳定MDMX,并在线粒体中促进其促凋亡功能。
Oncotarget. 2017 Feb 14;8(7):11053-11062. doi: 10.18632/oncotarget.14278.
9
CHFR negatively regulates SIRT1 activity upon oxidative stress.CHFR 在氧化应激下负调控 SIRT1 活性。
Sci Rep. 2016 Nov 24;6:37578. doi: 10.1038/srep37578.
10
Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.泛素连接酶UBR5对促凋亡蛋白MOAP-1的下调作用及其在卵巢癌顺铂耐药中的作用
Oncogene. 2017 Mar 23;36(12):1698-1706. doi: 10.1038/onc.2016.336. Epub 2016 Oct 10.